PRAX — PRAXIS PRECISION MEDICINES I

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in PRAXIS PRECISION MEDICINES I (PRAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 8,269 +5,189 +168.5% 0.00% $438K $53.00
2024 Q4 INITIATED 3,080 — — 0.00% $237K $76.96
% of Fund (quarterly)    PRAX price (monthly, adj. close)

Other funds also holding PRAX

As of 2025 Q4 — sorted by position size

72 Investment Holdings, LLC 3Y 38.42% Velan Capital Investment Management LP 3Y 17.23% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 16.62% Cormorant Asset Management, LP 3Y 7Y 12.95% PERCEPTIVE ADVISORS LLC 3Y 7Y 10.49% Exome Asset Management LLC 8.19% B Group, Inc. 7.23% Lion Point Capital, LP 3Y 7Y 6.79% Logos Global Management LP 3Y 6.68% Vivo Capital, LLC 3Y 7Y 6.27%
← Back to Freestone Grove Partners LP Holdings